Twin Tree Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Twin Tree Management's CRL Position: Q3 2026 in Review
Twin Tree Management opened a new position in Charles River Laboratories (CRL) in Q3 2026: 5,911 shares worth $1.74M. The stake represents 0.04% of the portfolio and ranks #560 among its holdings. This is a return to the name: Twin Tree Management previously reported a position in CRL as recently as Q3 2025.
Twin Tree Management first reported a position in CRL in Q2 2018 and has held it in 17 quarters since. The position peaked at $7.44M in Q1 2022. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Twin Tree Management held 5,911 shares of Charles River Laboratories worth $1.74M as of Q3 2026.
- Charles River Laboratories was a new Twin Tree Management position in Q3 2026.
- Charles River Laboratories made up 0.04% of Twin Tree Management's portfolio in Q3 2026, its #560 holding.
- Twin Tree Management first reported a position in Charles River Laboratories in Q2 2018 and has held it in 17 quarters since.
- Twin Tree Management's Charles River Laboratories position peaked at $7.44M in Q1 2022.
- 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Twin Tree Management's 13F filing for Q3 2026, filed 10 Nov 2026.